Celgene Continues Growing While Waiting for its Acquisition to Close

Celgene Continues Growing While Waiting for its Acquisition to Close

Submitted by admin on August 7, 2019 - 10:55am
Source: 
Motley Fool
News Tags: 
Celgene
earnings
M&A
Bristol-Myers Squibb
Headline: 
Celgene Continues Growing While Waiting for its Acquisition to Close
snippet: 

Celgene (NASDAQ: CELG) turned in a solid second quarter, allowing management to raise 2019 guidance as the company waits to be acquired by Bristol-Myers Squibb (NYSE: BMY).

Do Not Allow Advertisers to Use My Personal information